首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1358160

奈米抗體市場：按產品類型、按治療領域、按用途、按最終用戶、按地區

Nanobodies Market, By Product Type, By Therapeutic Area, By Application, By End User, By Geography

出版日期: 2023年09月25日 | 出版商:

Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2023 年，全球奈米抗體市場價值將達到 3.686 億美元，預測期內（2023-2030 年）年複合成長率為 24.1%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	3.686 億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	24.10%	2030年市場規模預測	16.719 億美元

奈米抗體全球市場佔有率(%)（依產品類型），2023 年

單域抗體，又稱“奈米抗體”，衍生哺乳動物重鏈抗體，其特徵是奈米級尺寸、剛性結構、在水溶液中穩定可溶性的行為、可逆的蛋白質折疊、以及高親和性等特殊特性。以及僅針對一個同源目標的特異性。奈米抗體具有從基礎科學到臨床治療的多種應用。奈米抗體的小尺寸和單域鏈提供了大的結合表面和低的特異性背景結合，使它們可用作親和捕獲試劑。此外，奈米抗體已被證明可以透過抑製血栓症交互作用來有效治療癌症，例如拮抗血管性血友病因子以預防血栓形成和抑制抗TNF-horse以治療關節炎，也可用於治療其他疾病。奈米抗體還可以在細胞內表達並與螢光蛋白融合以監測抗原活性。奈米抗體適合作為蛋白質穩定劑，這在蛋白質結晶中尤其重要。因此，奈米抗體因其能夠將蛋白質固定在特定構象並穩定軟性結構域而被用於許多蛋白質結晶研究。因此，奈米抗體的採用不斷增加，推動了奈米抗體市場的成長。

市場動態

奈米抗體市場的主要參與者正在投資研發，並專注於開發新產品以加強產品系列。因此，將此類先進產品引入市場預計將在預測期內推動全球奈米抗體市場的成長。例如，2020年10月，全球科技公司默克公司與全球醫療保健公司諾華公司合作開發了M6495，這是一種具有治療骨關節炎（OA）潛力的抗ADAMTS5奈米抗體。關於開發的許可協議這增加了骨關節炎患者的治療選擇。

本研究的主要特點

本報告詳細分析了全球奈米抗體市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率(CAGR) 。
它還揭示了各個細分市場的潛在收入機會，並為市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球奈米抗體市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、經營團隊升級、市場擴張和行銷策略做出明智的資訊。
全球奈米抗體市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球奈米抗體市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- Merck KGaA
- Sanofi
- AlpalifeB Inc
- GenScript
- Novartis International AG
- Taisho Pharmaceutical Holdings Co., Ltd.
- Sino Biological, Inc.
- GeneMedi
- Biocytogen
- Abnova Corporation
- NanoTag Biotechnologies
- Avillion LLP
- Capra Science
- Numab Therapeutics
- CUSABIO TECHNOLOGY LLC
- Proteintech Group, Inc.
- GT Biopharma, Inc.
- Confo Therapeutics
- R&D Systems, Inc.
- Abcepta Biotech Ltd. Co.
分析師觀點

第11章章節

參考
調查方法

簡介目錄

Product Code: CMI1680

The global nanobodies market is estimated to be valued at US$ 368.6 million in 2023 and is expected to exhibit a CAGR of 24.1% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 368.6 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	24.10%	2030 Value Projection:	US$ 1,671.9 Mn

Global Nanobodies Market Share (%), By Product Type, 2023

Single-domain antibodies known as "nanobodies" are derived from heavy-chain antibodies in mammals and have special characteristics such as nanoscale size, robust structure, stable and soluble behaviours in aqueous solution, reversible protein folding, high affinity and specificity for only one cognate target, among others. Nanobodies have a variety of applications, ranging from basic science to clinical therapeutics. Due to the small size and single-domain chain, nanobodies have a larger binding surface and lower nonspecific background binding and are used as affinity capture reagents. Furthermore, nanobodies can be used to treat cancer and other diseases by blocking ligand-receptor interactions, such as antagonizing the anti-von Willebrand factor to prevent thrombosis or inhibiting anti-TNF-α to treat arthritis. Nanobodies can also be expressed inside cells and fused with a fluorescent protein to monitor antigen activity. Nanobodies are well suited as protein stabilizers, which is particularly important during the crystallization of a protein. Thus, nanobodies are used in a number of protein crystallization studies due to the ability of nanobodies to lock proteins in a particular conformation stabilize flexible domains. This, increases the adoption of nanobodies and, thereby, drives the growth of the nanobodies market.

Market Dynamics

The key players in the nanobodies market are focusing on the development of new products by investing in research and development to strengthen their product portfolio. Thus, the introduction of such advanced products in the market is expected to drive growth of the global nanobodies market over the forecast period. For instance, in October 2020, Merck KGaA, a global science and technology company, entered into an out-licensing agreement with Novartis AG, a global healthcare company, for the development of M6495, an anti-ADAMTS5 nanobody, for the potential treatment of osteoarthritis (OA). This increased treatment option for osteoarthritis patients.

Key features of the study:

The report provides an in-depth analysis of the global nanobodies market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for the market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global nanobodies market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of thestudy include Merck KGaA, Sanofi, AlpalifeB Inc, GenScript, Novartis International AG, Taisho Pharmaceutical Holdings Co., Ltd., Sino Biological, Inc., GeneMedi, Biocytogen, Abnova Corporation, NanoTag Biotechnologies, Avillion LLP, Capra Science, Numab Therapeutics, CUSABIO TECHNOLOGY LLC, Proteintech Group, Inc., GT Biopharma, Inc., Confo Therapeutics, R&D Systems, Inc., Abcepta Biotech Ltd. Co.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global nanobodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nanobodies market

Detailed Segmentation:

Global Nanobodies Market, By Product Type:
- Monovalent Nanobodies
- Bivalent Nanobodies
- Bispecific Nanobodies
- Biparatopic Nanobodies
- Multivalent Nanobodies
- Fusion Nanobodies
Global Nanobodies Market, By Therapeutic Area:
- Oncology
- Infectious Diseases
- Inflammatory and Autoimmune Diseases
- Neurological Disorders
- Others
Global Nanobodies Market, By Application:
- Therapeutic
- Diagnostic
- Research
Global Nanobodies Market, By End User:
- Hospitals
- Biopharmaceutical Companies
- Diagnostic Laboratories
- Others
Global Nanobodies Market, By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Company Profiles
- Merck KGaA
- Sanofi
- AlpalifeB Inc
- GenScript
- Novartis International AG
- Taisho Pharmaceutical Holdings Co., Ltd.
- Sino Biological, Inc.
- GeneMedi
- Biocytogen
- Abnova Corporation
- NanoTag Biotechnologies
- Avillion LLP
- Capra Science
- Numab Therapeutics
- CUSABIO TECHNOLOGY LLC
- Proteintech Group, Inc.
- GT Biopharma, Inc.
- Confo Therapeutics
- R&D Systems, Inc.
- Abcepta Biotech Ltd. Co.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Therapeutic Area
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Opportunities
- Recent Trends
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- PORTER's Analysis

4. Global Nanobodies Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Nanobodies Market, By Product Type, 2018- 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Monovalent Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Bivalent Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Bispecific Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Biparatopic Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Multivalent Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Fusion Nanobodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends

6. Global Nanobodies Market, By Therapeutic Area, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Inflammatory and Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends

7. Global Nanobodies Market, By Application, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Therapeutic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Diagnostic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends

8. Global Nanobodies Market, By End User, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
- Segment Trends

9. Global Nanobodies Market, By Region, 2018 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
North America
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.S.
Canada
Europe
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast,Y-o-Y Growth, By Product Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Therapeutic Area, 2018-2030, (US$ Mn)
- Market Size and Forecast, Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
- Market Size and Forecast,Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profiles
- Merck KGaA
- Sanofi
- AlpalifeB Inc
- GenScript
- Novartis International AG
- Taisho Pharmaceutical Holdings Co., Ltd.
- Sino Biological, Inc.
- GeneMedi
- Biocytogen
- Abnova Corporation
- NanoTag Biotechnologies
- Avillion LLP
- Capra Science
- Numab Therapeutics
- CUSABIO TECHNOLOGY LLC
- Proteintech Group, Inc.
- GT Biopharma, Inc.
- Confo Therapeutics
- R&D Systems, Inc.
- Abcepta Biotech Ltd. Co.
Analysts' Views

11. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

奈米抗體市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、按最終用戶的應用、按地區、按競爭，2019-2029F

奈米抗體市場報告：2030 年趨勢、預測與競爭分析

2030年全球奈米抗體市場預測

FAQ

奈米抗體市場：按產品類型、按治療領域、按用途、按最終用戶、按地區